224 related articles for article (PubMed ID: 37830597)
1. Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus.
Garcia G; Chakravarty N; Paiola S; Urena E; Gyani P; Tse C; French SW; Danielpour M; Breunig JJ; Nathanson DA; Arumugaswami V
Cells; 2023 Sep; 12(19):. PubMed ID: 37830597
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
[TBL] [Abstract][Full Text] [Related]
3. Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells.
Victorio CBL; Novera W; Ganasarajah A; Ong J; Thomas M; Wu J; Toh HSY; Sun AX; Ooi EE; Chacko AM
J Transl Med; 2024 Feb; 22(1):126. PubMed ID: 38308299
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic Zika Virus: New Option for Glioblastoma Treatment.
Zhou C; Chen Q; Chen Y; Qin CF
DNA Cell Biol; 2023 Jun; 42(6):267-273. PubMed ID: 36350682
[TBL] [Abstract][Full Text] [Related]
5. Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy.
Calderón-Peláez MA; Maradei Anaya SJ; Bedoya-Rodríguez IJ; González-Ipuz KG; Vera-Palacios D; Buitrago IV; Castellanos JE; Velandia-Romero ML
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675903
[TBL] [Abstract][Full Text] [Related]
6. Zika virus has oncolytic activity against glioblastoma stem cells.
Zhu Z; Gorman MJ; McKenzie LD; Chai JN; Hubert CG; Prager BC; Fernandez E; Richner JM; Zhang R; Shan C; Tycksen E; Wang X; Shi PY; Diamond MS; Rich JN; Chheda MG
J Exp Med; 2017 Oct; 214(10):2843-2857. PubMed ID: 28874392
[TBL] [Abstract][Full Text] [Related]
7. Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.
Nair S; Mazzoccoli L; Jash A; Govero J; Bais SS; Hu T; Fontes-Garfias CR; Shan C; Okada H; Shresta S; Rich JN; Shi PY; Diamond MS; Chheda MG
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232299
[TBL] [Abstract][Full Text] [Related]
8. Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment.
Francipane MG; Douradinha B; Chinnici CM; Russelli G; Conaldi PG; Iannolo G
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681654
[TBL] [Abstract][Full Text] [Related]
9. CDK4/6 Inhibition Enhances Oncolytic Virus Efficacy by Potentiating Tumor-Selective Cell Killing and T-cell Activation in Refractory Glioblastoma.
Xiao J; Liang J; Fan J; Hou P; Li X; Zhang H; Li K; Bu L; Li P; He M; Zhong Y; Guo L; Jia P; Xiao Q; Wu J; Peng H; Li C; Xing F; Guo D
Cancer Res; 2022 Sep; 82(18):3359-3374. PubMed ID: 35792620
[TBL] [Abstract][Full Text] [Related]
10. Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells
Kaid C; Goulart E; Caires-Júnior LC; Araujo BHS; Soares-Schanoski A; Bueno HMS; Telles-Silva KA; Astray RM; Assoni AF; Júnior AFR; Ventini DC; Puglia ALP; Gomes RP; Zatz M; Okamoto OK
Cancer Res; 2018 Jun; 78(12):3363-3374. PubMed ID: 29700002
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic Effect of Zika Virus in Neuroendocrine Pancreatic Tumors: New Perspectives for Therapeutic Approaches.
Cocco MM; Carcione C; Miceli V; Tinnirello R; Chinnici CM; Carbone C; Zito G; Conaldi PG; Iannolo G
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139100
[TBL] [Abstract][Full Text] [Related]
12. Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors.
Novaes GM; Lima C; Longo C; Machado PH; Silva TP; Olberg GGO; Módolo DG; Pereira MCL; Santos TG; Zatz M; Lagares D; de Franco M; Ho PL; Bulstrode H; Okamoto OK; Kaid C
Mol Ther; 2024 Feb; 32(2):440-456. PubMed ID: 38213031
[TBL] [Abstract][Full Text] [Related]
13. A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.
Kanai R; Wakimoto H; Martuza RL; Rabkin SD
Clin Cancer Res; 2011 Jun; 17(11):3686-96. PubMed ID: 21505062
[TBL] [Abstract][Full Text] [Related]
14. Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin α
Zhu Z; Mesci P; Bernatchez JA; Gimple RC; Wang X; Schafer ST; Wettersten HI; Beck S; Clark AE; Wu Q; Prager BC; Kim LJY; Dhanwani R; Sharma S; Garancher A; Weis SM; Mack SC; Negraes PD; Trujillo CA; Penalva LO; Feng J; Lan Z; Zhang R; Wessel AW; Dhawan S; Diamond MS; Chen CC; Wechsler-Reya RJ; Gage FH; Hu H; Siqueira-Neto JL; Muotri AR; Cheresh DA; Rich JN
Cell Stem Cell; 2020 Feb; 26(2):187-204.e10. PubMed ID: 31956038
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models.
Saha D; Wakimoto H; Peters CW; Antoszczyk SJ; Rabkin SD; Martuza RL
Clin Cancer Res; 2018 Jul; 24(14):3409-3422. PubMed ID: 29599413
[No Abstract] [Full Text] [Related]
16. Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells.
Trus I; Berube N; Jiang P; Rak J; Gerdts V; Karniychuk U
Viruses; 2020 May; 12(5):. PubMed ID: 32466170
[TBL] [Abstract][Full Text] [Related]
17. Effect of Serial Systemic and Intratumoral Injections of Oncolytic ZIKV
Ferreira RO; Granha I; Ferreira RS; Bueno HS; Okamoto OK; Kaid C; Zatz M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696533
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts.
Cheema TA; Kanai R; Kim GW; Wakimoto H; Passer B; Rabkin SD; Martuza RL
Clin Cancer Res; 2011 Dec; 17(23):7383-93. PubMed ID: 21976549
[TBL] [Abstract][Full Text] [Related]
19. Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
Esaki S; Nigim F; Moon E; Luk S; Kiyokawa J; Curry W; Cahill DP; Chi AS; Iafrate AJ; Martuza RL; Rabkin SD; Wakimoto H
Int J Cancer; 2017 Dec; 141(11):2348-2358. PubMed ID: 28801914
[TBL] [Abstract][Full Text] [Related]
20. Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.
Koch MS; Zdioruk M; Nowicki MO; Griffith AM; Aguilar E; Aguilar LK; Guzik BW; Barone F; Tak PP; Tabatabai G; Lederer JA; Chiocca EA; Lawler S
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
